Skip to content

Influence of magnetic resonance diffusion tensor imaging technology on clinical efficacy of percutaneous spinal endoscopy in the treatment of lumbar disc herniation

Influence of magnetic resonance diffusion tensor imaging technology campared with traditional magnetic resonance imaging on clinical efficacy: A prospective randomized controlled study

Status
Active, not recruiting
Phases
Early Phase 1
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2200060309
Enrollment
Unknown
Registered
2022-05-27
Start date
2022-05-15
Completion date
Unknown
Last updated
2024-05-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

lumbar disc herniation

Interventions

Group 1 :
Group 2:

Sponsors

The First Affiliated Hospital of Nanjing Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1. Medical history of unilateral or bilateral low back pain; 2. Central and paracentral lumbar disc herniation, axillary and suprascapular lumbar disc herniation, free prolapse lumbar disc herniation (including cephalic or caudal prolapse), extreme lateral lumbar disc herniation; 3. Recurrent lumbar disc herniation; 4. After more than 3 months of strict non-surgical treatment is invalid.

Exclusion criteria

Exclusion criteria: 1. Herniated disc with bony spinal stenosis; 2. With lumbar instability, spondylolisthesis, lumbar infection, and spinal deformity; 3. Combined with surgical area infection, abnormal coagulation function, tumor and other pathological abnormalities.

Design outcomes

Primary

MeasureTime frame
The modified Macnab standard was used to evaluate the postoperative efficacy and calculate the excellent and good rate;

Secondary

MeasureTime frame
Visual Analogue Scale, VAS ;The Oswestry Disability Index (ODI) ;Quality of Life Rating Scale (SF-36);

Countries

China

Contacts

Public ContactRen Yongxin

The First Affiliated Hospital of Nanjing Medical University

renyongxin@aliyun.com+86 13585162283

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026